{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:05:49Z","timestamp":1765609549406},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T00:00:00Z","timestamp":1363910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059765","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:35:10Z","timestamp":1363991710000},"page":"e59765","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay"],"prefix":"10.1371","volume":"8","author":[{"given":"Sarah","family":"Preisler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matejka","family":"Rebolj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Untermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte M\u00f8ller","family":"Ejegod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Rygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"J Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"G Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"DC Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrclinonc.2009.167","article-title":"Primary HPV screening for cervical cancer prevention: results from European trials","volume":"6","author":"E Lynge","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"D Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"CJ Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPRI8XPQUEAA3K","article-title":"Special commentary: patient safety and the next generation of HPV DNA tests","volume":"134","author":"W Kinney","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013Part B: biological agents","volume":"10","author":"V Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"N Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"D Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"TC Wright Jr","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"PE Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"TC Wright Jr","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors 2 study","volume":"50","author":"A Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/JCM.06656-11","article-title":"Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix","volume":"50","author":"SG Lapierre","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2011.07.024","article-title":"Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS\/LSIL, prediction of CIN2\u20133 in follow up biopsies and spontaneous regression of CIN2\u20133","volume":"123","author":"IT Ovestad","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/JCM.00725-09","article-title":"Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping","volume":"47","author":"PE Castle","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/JCM.05989-11","article-title":"Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests","volume":"50","author":"JC Gage","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1951.17","article-title":"The social distribution of cancer in Copenhagen, 1943 to 1947","volume":"5","author":"J Clemmesen","year":"1951","journal-title":"Br J Cancer"},{"key":"ref20","unstructured":"Styregruppen for DKLS (2011) \u00c5rsrapport DKLS 2010: Dansk Kvalitetsdatabase for Livmoderhalskr\u00e6ftscreening [Annual report 2010: Danish Quality Assurance database for cervical cancer screening]. URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.sundhed.dk\/Fil.ashx?id=15486&ext=pdf&navn=DKLS_aarsrapport_2010.pdf\" xlink:type=\"simple\">https:\/\/www.sundhed.dk\/Fil.ashx?id=15486&amp;ext=pdf&amp;navn=DKLS_aarsrapport_2010.pdf<\/ext-link>. Last accessed: 21 November 2011."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"B Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"ref22","unstructured":"Cobas\u00ae HPV Test [package insert]. Branchburg, NJ, USA: Roche Molecular Systems. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/e-labdoc.roche.com\" xlink:type=\"simple\">http:\/\/e-labdoc.roche.com<\/ext-link>, last accessed for the study august 2012."},{"key":"ref23","unstructured":"QIASymphony [package insert]. Gaithersburg, MD, USA: Qiagen. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.qiagen.com\/literature\/render.aspx?id=201094\" xlink:type=\"simple\">www.qiagen.com\/literature\/render.aspx?id=201094<\/ext-link>. Accessed 21 August 2012."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/jnci\/dji159","article-title":"Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests","volume":"97","author":"S Franceschi","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"L Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/JCM.05552-11","article-title":"Clinical validation of the cobas 4800 HPV test for cervical screening purposes","volume":"49","author":"DA Heideman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","volume":"123","author":"SK Kjaer","year":"2008","journal-title":"Int J Cancer"},{"key":"ref28","unstructured":"Austin RM (undated) URL: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/laboratory-manager.advanceweb.com\/features\/top-story\/liquid-based-cytology-vs-conventional-cytology.aspx?CP=3\" xlink:type=\"simple\">http:\/\/laboratory-manager.advanceweb.com\/features\/top-story\/liquid-based-cytology-vs-conventional-cytology.aspx?CP=3<\/ext-link>. Accessed 14 March 2012."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/JCM.05400-11","article-title":"Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium","volume":"50","author":"AA Wong","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00337-12","article-title":"Clinical performances of the Abbott RealTime High Risk HPV, Roche Cobas HPV and Hybrid Capture 2 assays compared to direct sequencing and genotyping of HPV DNA","volume":"50","author":"Y Park","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2011.12.002","article-title":"Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples","volume":"180","author":"SB Martinez","year":"2012","journal-title":"J Virol Methods"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jmoldx.2011.09.005","article-title":"Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes","volume":"14","author":"ML Lindemann","year":"2012","journal-title":"J Mol Diagn"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"P Naucler","year":"2009","journal-title":"J Natl Cancer Inst"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:21:47Z","timestamp":1540336907000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059765"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,22]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059765","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,22]]}}}